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Is body weight the most appropriate criterion
to select patients eligible for low-dose
pulmonary CT angiography? Analysis
of objective and subjective image quality
at 80 kVp in 100 patients
Abstract The objective of this retro-
spective study was to assess image
quality with pulmonary CT angiogra-
phy (CTA) using 80 kVp and to find
anthropomorphic parameters other
than body weight (BW) to serve as
selection criteria for low-dose CTA.
Attenuation in the pulmonary arteries,
anteroposterior and lateral diameters,
cross-sectional area and soft-tissue
thickness of the chest were measured
in 100 consecutive patients weighing
less than 100 kg with 80 kVp pulmo-
nary CTA. Body surface area (BSA)
and contrast-to-noise ratios (CNR)
were calculated. Three radiologists
analyzed arterial enhancement, noise,
and image quality. Image parameters
between patients grouped by BW
(group 1: 0–50 kg; groups 2–6: 51–
100 kg, decadally increasing) were
compared. CNR was higher in patients
weighing less than 60 kg than in the
BW groups 71–99 kg (P between
0.025 and <0.001). Subjective ranking
of enhancement (P=0.165–0.605),
noise (P=0.063), and image quality
(P=0.079) did not differ significantly
across all patient groups. CNR corre-
lated moderately strongly with weight
(R=−0.585), BSA (R=−0.582), cross-
sectional area (R=−0.544), and an-
teroposterior diameter of the chest
(R=−0.457; P<0.001 all parameters).
We conclude that 80 kVp pulmonary
CTA permits diagnostic image quality
in patients weighing up to 100 kg.
Body weight is a suitable criterion to
select patients for low-dose pulmona-
ry CTA.
Keywords Pulmonary CT
angiography . Radiation exposure .
Image quality
Introduction
The use of low tube energy is a very attractive way to reduce
patient exposure with CT angiography (CTA), since the
attenuation of iodinated contrast media increases at low kVp
[1–3]. The method is especially interesting for use with the
chest, where the increase in image noise at low kilovoltage is
less pronounced due to the low x-ray absorption of the lungs
[4]. Clinical studies have already confirmed the practicability
of 100 kVp pulmonary CTA protocols to provide a good
contrast-to-noise ratio (CNR) and subjective image quality at
a reduced radiation dose, as compared to 120 and 140 kVp
[5, 6]. It has also been shown that the use of 80 kVp offers a
further reduction in patient exposure by 40% compared to
100 kVp in patients weighing less than 100 kg [7].
Nevertheless, there is a concern that increasing noise in
patients weighing more than 80 kg could deteriorate image
quality. Furthermore, other patient measures, such as body
mass index (BMI), body surface area (BSA), or transverse
chest dimension, could also be eligible parameters to select
patients in whom 80 kVp pulmonary CTA delivers diagnos-
tic image quality. However, the impact of these parameters
on image quality in pulmonary CTA is less known.
Therefore, the aim of our retrospective study was to
assess if image quality is sufficient with pulmonary CTA
using 80 kVp in patients weighing up to 100 kg and to find
the anthropomorphic parameter that best correlates with
objective and subjective image quality.
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Materials and methods
Patients
In November 2007, we optimized our routine pulmonary
CTA protocol based on scientific evidence [4, 8]. Since
then, patients with suspected pulmonary embolism (PE)
and weight less than 100 kg have been routinely examined
using a tube voltage of 80 kVp, while 100 kVp has been
used in patients weighing more than 100 kg or those with
other indications than PE. Our electronic database was
retrospectively searched for pulmonary CTAs performed
between November 2007 and August 2008. Ten percent of
patients weighed more than 100 kg and were examined
with 100 kV. The last 100 consecutive patients with body
weights of less than 100 kg and examined with 80 kVp
pulmonary CTAwere enrolled in this study. Patient weight
and height were recorded in the examination protocol. The
indication of pulmonary CTAwas based on patient history,
clinical examination, elevated level of D-dimers, and/or
positive results of duplex sonography of the lower limbs.
The institutional review board approved the retrospective
study protocol, and informed consent was waived.
Pulmonary CTA protocol
All patients were examined with a 16-row CT system
(Somatom Sensation 16, Siemens, Erlangen, Germany),
using real-time automatic mAs-modulation (CareDose4D).
Parameters of data acquisition (80 kVp tube energy, quality
reference mAs of 150, 16×0.75 mm collimation, 0.5 s tube
rotation time, and 1.15 pitch) were kept constant. Seventy-
five milliliters of commercially available contrast medium
(CM) with 300 mgI/mL (iobitridol, Xenetix 300, Guerbet,
Aulnay-sous-Bois, France) was administered in an ante-
cubital vein through a 20- or 18-gauge canula at a flow-rate
of 3 mL/s using a standard injector (Envision CT, Medrad,
Pittsburgh, PA). Bolus tracking (Care Bolus, Siemens) was
used for optimal timing of the CM in the pulmonary
arteries. Image acquisition was started 4 s after reaching the
threshold of 100 Hounsfield units (HU) in the main
pulmonary artery. Transverse images were reconstructed at
5 and 1 mm using a standard kernel (B30f). Overlapping
maximum intensity projections (MIP; 10 mm thick) in the
coronal plane were calculated at 2-mm increments on the
workstation provided by the manufacturer. These MIP
reconstructions are routinely used at our institute to aid in
localizing pulmonary emboli. All images were stored in
PACS.
Analysis of quantitative image parameters
Quantitative image parameters were analyzed by Z.S.F. and
L.K. The anteroposterior (AP) and lateral chest diameter
were measured in all patients at the level of the pulmonary
trunk. At the same level, the outer margin of the chest was
traced manually to obtain the transverse cross-sectional
area. The thickness of the soft tissues of the chest wall was
measured between the ventral surface of the sternum and
skin and from the dorsal skin to the plane of the transverse
processes of the thoracic vertebra, usually of Th 6. (Fig. 1).
BMI was defined as follows: BMI=weight (kg)/height
(m)2. The scaling formula was used to estimate BSA: BSA
(m2)=[0.1173×weight (kg)]0.6466 [9].
Attenuation was measured in the pulmonary trunk, the
left and right pulmonary arteries, the five lobar pulmonary
arteries, and the lingular artery (nine arteries) on the 1-mm-
thick transverse images by placing circular regions of
interest (ROI) in the center of the contrasted vessels
(SIvessel). Each artery was measured in its proximal,
middle, and distal thirds, and the mean of these values
was used for further calculations. The ROI size was
adapted to the vessel diameter and varied between 80 and
100 mm2 in the pulmonary trunk. The attenuation in the
peripheral pulmonary arteries was evaluated by reporting
the highest window level at which the vessels were just
visualized on the monitor using a window width of one.
The mean of the window levels obtained with this method
in the upper, middle, and lower thirds of the chest was used
as the arterial attenuation on the periphery. Values in the
central and peripheral arteries were averaged to obtain the
Fig. 1 Transverse CT image (5 mm thick) at the level of the main
pulmonary artery demonstrating the morphologic measurements
used in the study. The 65-year-old male patient underwent a 80 kVp
pulmonary CT angiography with the clinical suspicion of pulmonary
embolism. The area enclosed by the white solid line corresponds to
the transverse cross-sectional area of the chest. The sum of the
distances signaled by the anterior and posterior black vertical
arrows equals the soft-tissue thickness of the chest wall. The lateral
chest diameter is marked by the white dashed line. The distance
between the points A and P represents the anteroposterior chest
diameter. The asterisk marks an embolus in the left lower lobe
pulmonary artery
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mean attenuation of the pulmonary arteries. An attenuation
threshold of 300 HU was used as a criterion for optimal
vessel enhancement as proposed in the literature [10].
Aortic attenuation was measured in the ascending aorta
at the level of the pulmonary trunk. The ratio of the
attenuations in the main pulmonary artery and aorta was
used to characterize if the imaging was timed correctly. A
ratio above 1 was accepted as correct timing, and a ratio
below 1, i.e., a higher signal in the aorta compared to the
main pulmonary artery, was regarded as a delayed start of
the imaging.
Noise was defined as the mean of the standard
deviations of the CT numbers measured in three ROIs
placed in the pulmonary trunk. Background signal
(SIbackgr) was defined as the average attenuation mea-
sured in the paraspinal muscles at the level of the
pulmonary trunk. The signal-to-noise ratio (SNR) and
contrast-to-noise ratio (CNR) were calculated separately
for the central and peripheral pulmonary arteries as
follows: SNR=SIvessel/noise and CNR=(SIvessel−
SIbackgr)/noise.
CT dose index (CTDIvol) was noted for each patient.
The estimated effective dose was calculated by multi-
plying CTDIvol by the scan length and the correction
factor of 0.016 mSv/(mGy×cm), which was proposed
for our CT scanner at 80 kVp in the chest [11]. By
definition, CTDIvol only characterizes absorbed dose
correctly in intermediate patients but not in thin or
obese patients. Thus, dose values were not used for
comparisons between the weight groups.
Analysis of subjective image quality
Three radiologists (T.S., S.T.S., M.A.P.) with CT experi-
ence of 10 months, 4 years, and 10 years, independently
evaluated all pulmonary CTA examinations. To standardize
the evaluation, five patients not included in the study were
read in consensus prior to the qualitative assessment. The
observers rated arterial enhancement separately in the
main, left, and right pulmonary arteries, in all lobar arteries,
and the lingular artery on a five-point scale (1 = bad; 5 =
excellent). Image noise was assessed both in the pulmonary
arteries and the mediastinum (1 = major, 2 = substantial,
3 = moderate, 4 = minor, 5 = none). Causes of reduced
image quality (related to CM flow, bolus timing, obesity,
motion, lung pathology, and external metallic artifacts)
were recorded. All parameters were separately assessed
both on the 1-mm-thick transverse slices and coronal MIP
images. Adjustment of window level and width was
allowed. The readers also reported the most distal
detectable ramification of the pulmonary arteries and the
overall image quality on a five-point scale (1 = bad, no
diagnosis possible; 2 = poor, diagnostic confidence
significantly reduced; 3 = moderate, but sufficient for
diagnosis; 4 = good; 5 = excellent).
Both quantitative and qualitative image analyses were
performed on high-definition LCD monitors routinely used
for reporting CT images (ME355i2, Totoku Electric,
Japan).
Statistical analysis of data
Statistical analysis was performed with the Statistica 7
software package (StatSoft, Tulsa, OK) and the MedCalc
software (MedCalc, Mariakerke, Belgium). A P value less
than 0.05 was considered statistically significant. Patient
data and image parameters were tested for normal distri-
bution with the Shapiro-WilkW test. Patients were grouped
by body weight into six groups (group 1: 0–50 kg, group 2:
51–60 kg, group 3: 61–70 kg, group 4: 71–80 kg, group 5:
81–90 kg, and group 6: 91–99 kg). The parameters with
normal distribution were compared between the groups
using the analysis of variance (ANOVA) and post-hoc tests.
Non-normally distributed data were analyzed by the
Kruskal-Wallis test. Pearson’s r was used to characterize
the correlation between continuous variables and Spear-
man’s R was applied for the same purpose in nonparame-
trical data. The linear regression model was used to
describe the relationship between CNR in the pulmonary
arteries and subjective image quality and each of the
following parameters: weight, BMI, BSA, chest AP
diameter, chest cross-sectional area, and soft-tissue thick-
ness of the chest wall. The effect of the morphologic
parameters on CNR and subjective image quality was
analyzed by forward stepwise regression.
The interobserver agreement regarding overall image
quality was assessed using Cohen’s kappa statistics.
Results
All morphological patient data were normally distributed
(P> 0.05). Age, attenuation in pulmonary arteries, noise,
SNR, CNR, and rankings given by the readers showed non-
normal distributions (P<0.05). The mean CTDIvol in the
100 patients was 3.59±0.46 mGy corresponding to an
estimated effective dose of 1.9±0.29 mSv.
Demographic and morphological patient data
Except for age, all demographic and morphometric
patient data were significantly different between patient
groups with various weights (Table 1). Comparing the
consecutive weight groups yielded a significant differ-
ence only between the 51–60 and 61–70 kg groups for
BMI (P=0.005), the AP and lateral diameters (P=0.016
and 0.002), and cross-sectional area (P<0.001) of the
chest. Weight and BSA were constantly increasing
across the groups (P<0.001).
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Objective and subjective image quality in different
body-weight groups
There was a trend toward lower attenuations in the
pulmonary arteries as patient weight increased, but the
differences between the weight groups did not reach
statistical significance (P=0.089, Table 2). We measured
significantly higher noise in patients with body weights
above 80 kg compared to those weighing less than 60 kg
(Table 3). CNR decreased with increasing body weight,
reaching statistical significance for body-weight groups
71–99 kg compared to patients weighing 60 kg or less (P
between 0.025 and <0.001; Fig. 2).
The readers rated image quality better at higher atten-
uation and CNR in the pulmonary arteries (R=0.583 and
0.591; P<0.001). There was no apparent relationship
between the subjective image quality and measured image
noise (P=0.36).
The subjective grading of enhancement in the separately
analyzed arteries (P=0.165–0.605), noise in the vessels
(P=0.063), and noise in the mediastinum (P=0.094) yielded
no significant difference across the patient groups. The readers
could delineate pulmonary arteries virtually to the same level
of ramification in all patients (P=0.656). The differences in
overall image quality between consecutive patient groups
were not significant (P=0.26–1.0). The mean interobserver
agreement for overall image quality was κ=0.40.
Patients with delayed start of CT acquisition
and suboptimal enhancement
In 10 patients, the attenuation in the ascending aorta was
higher than in the main pulmonary artery due to a delayed
start of CT data acquisition. In these patients, the attenuation
in all pulmonary arteries (309.9±78 vs. 429.8±115 HU,
P=0.002), CNR (16.7±2.9 vs. 23.6±8.6,P=0.005), subjective
vessel enhancement (3.89±0.57 vs. 4.41±0.43,P<0.001), and
image quality (3.63±0.53 vs. 4.04±0.53, P=0.023) were
significantly lower compared to the other 90 patients. In 5
out of 10 patients (50%), the mean pulmonary arterial
attenuation was lower than 300 HU, corresponding to a
suboptimal enhancement. In two patients weighing 60 and
74 kg, the mean quality rating by the readers was 2.67
(moderate to poor). Image quality was moderate or better in
all other patients.
Attenuation in the pulmonary arteries exceeded 300 HU
in all but six patients (6.7%) with correct bolus timing.
These six patients had an average weight of 72.7 kg and a
BSA of 1.87 m2, which were not different from the rest of
the population (P=0.66 and 0.48, respectively).
Effect of anthropomorphic parameters on image
quality
CNR correlated best with weight and BSA and worst with
BMI (Table 3). The linear regression calculations on CNR
yielded moderately high r values for BSA, weight, and
transverse area of the chest (Fig. 3). Correlations between
subjective image quality and morphologic patient data
were weak, with the cross-sectional chest area showing the
second highest R value after weight (Table 4).
From the stepwise regression analysis, body weight
showed the largest effect on CNR (beta=−0.60, P<0.001),
followed by BSA (beta=−0.59; P<0.001); the beta values
for the other morphologic parameters were not significant.
The stepwise regression model on the subjective image
Table 1 Descriptive statistics of demographic and morphologic data of 100 consecutive patients examined at 80 kVp pulmonary CTA
All patients Patients grouped by body weight P
0–50 kg 51–60 kg 61–70 kg 71–80 kg 81–90 kg 91–99 kg
Number 100 7 20 25 28 14 6
Female/male 51/49 7/0 16/4 11/14 14/14 3/11 0/6
Age (years) 62.3±15.5 57.3±22.4 58.7±20.0 65.1±13.1 63.3±13.6 63.1±14.7 61.0±9.8 0.734
Weight (kg) 70.6±12.7 47.1±2.3 57.3±2.9 67.3±2.1 75.9±2.4 85.5±2.9 96.0±1.7 <0.001
Height (cm) 169.0±9.8 155.3±6.8 164.4±7.3 167.6±8.7 171.0±9.1 176.4±6.0 179.5±9.1 <0.001
BMI (kg/m2) 24.7±3.7 19.7±2.2 21.3±1.5 24.2±2.6 26.2±3.1 27.6±2.0 30.0±2.8 <0.001
BSA (m2) 1.81±0.2 1.43±0.0 1.62±0.1 1.77±0.1 1.90±0.1 2.0±0.1 2.2±0.1 <0.001
Chest AP diameter (cm) 22.9±2.7 20.2±2.7 20.6±1.8 23.1±2.1 23.6±2.7 24.7±1.5 26.0±1.3 <0.001
Chest transverse area (cm2) 693.2±128 522.6±60 557.8±68 696.1±59 730±88 835.4±84 871.8±68 <0.001
Chest soft-tissue thickness (cm) 4.0±1.2 3.0±0.6 3.2±0.7 3.9±1.0 4.3±1.1 5.2±1.3 5.6±0.9 <0.001
Data are means and standard deviations. Parameters describing the transverse chest dimensions were measured at the level of the main
pulmonary artery. The last column contains P values from comparing patients grouped by body weight
BMI Body mass index, BSA body surface area, AP anteroposterior
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quality found no significant beta values for the morpho-
logical patient data.
Discussion
In the current series we retrospectively analyzed 100
low-dose pulmonary CTAs using 80 kVp in patients with
a body weight of less than 100 kg. The objective and the
subjective image qualities were broadly similar in all
patients between 50 and 100 kg. We found that body
weight is the simplest and most suitable parameter to
select patients eligible for low kilovoltage pulmonary
CTA.
It is widely accepted that heavy patients need more CM
than slim individuals to reach the same vessel enhancement
during CTA. In the last 2 years, body weight, BSA, and
body fat percentage have all been proposed as factors
reflecting blood vessel volume and thus, as the basis to
calculate contrast-material dose for CTA [10, 12–14].
Recently, a chest-phantom study, simulating stationary
conditions and ignoring effects of dilution or dispersion,
presented decreased attenuation of iodinated contrast
media with increasing transverse dimension of the phan-
tom. The observation was explained by beam hardening
and the higher fraction of scattered radiation [8]. Thus, it
seems obvious that the cross-sectional dimensions of the
examined region should have an effect not only on noise
but also on enhancement in patients examined with CTA.
Since the aerated lungs represent low attenuation and bone
thickness is minimally variable with patient weight in
adults, x-ray absorption of the chest is expected to be
attributed mainly to the variable thickness of the soft
tissues of the chest wall.
Our findings only verified these assumptions in part.
Cross-sectional area showed the strongest correlation with
CNR among the parameters describing the transverse chest
dimension. However, cross-sectional area is dependent on
the position of the breasts in females and its measurement
needs a large enough field of view. Furthermore, CNR
correlated best with weight, which makes the cumbersome
area measurement unnecessary. BSA, which was derived
directly from weight and ignored other factors including
height, showed a somewhat lower correlation with objec-
tive image quality. Therefore, weight seems to be the
simplest suitable parameter to select patients in whom low-
kVp CTA will yield diagnostic image quality. The corre-
lation between vessel enhancement and body surface area
and body weight, respectively, was worse than that found
by Bae et al. [12] and comparable with the results of other
investigators [15, 16].
The most important outcome of our study is the
verification of good image quality of low-dose pulmonary
CTA using 80 kVp in patients weighing up to 100 kg. Our
routine pulmonary CTAwith a mean effective dose of less
than 2 mSv represents a significant reduction in patient
exposure compared to the mean dose of 15 mSv (range,
13–40 mSv) of the currently used pulmonary CTA
protocols as reported by Mettler et al. [17]. This is only
an approximate comparison since we did not include patients
with a body weight of more than 100 kg, which, however,
corresponded only to 10% of all patients referred to us with
Table 3 Detailed list of P values from comparison of body-weight groups with regard to noise (lower left) and contrast-to-noise ratio (CNR,
upper right)
N
oi
se
CNR
C
N
R
0-50 kg 51-60 kg 61-70 kg 71-80 kg 81-90 kg 91-99 kg
0-50 kg 1.0 0.395 0.025* 0.004* 0.001*
51-60 kg 1.0 0.239 0.003* <0.001* <0.001*
61-70 kg 0.269 0.011* 1.0 0.266 0.036*
71-80 kg 1.0 0.851 1.0
1.0
1.0
1.0 0.397
81-90 kg 0.042* 0.001* 0.135 1.0
91-99 kg 0.031* 0.004* 0.126 1.0
Noise
Significant results are marked with asterisks
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suspected PE. The fraction of patients ineligible for 80 kVp
can be higher in populations with more obese individuals.
Although the mean CNR and subjective image quality
decreased at higher body weights, no cut-off value was
found above which image quality was moderate or worse.
Interestingly, subjective quality correlated with vessel
enhancement but not with image noise. Personal commu-
nications with the readers revealed that they had adjusted
window settings to the high vascular attenuation and thus
eliminated the disturbing effect of noise at 80 kVp.
The volume of contrast medium was kept constant in our
series and was not adapted to body weight or BSA. It has
been shown that the calculation of administered contrast
medium based on body weight can optimize vessel
enhancement at CTA and reduce iodine load [15, 18, 19].
However, timing becomes much more crucial if the
injection time is very short due to small CM volume. In
our experience, the start of image acquisition may be
delayed in thin young adults with good cardiac function,
resulting in suboptimal quality and occasionally in the need
to repeat the examination. In this group of patients, the time
the CT table needs to move from the triggering site to the
scanning start position at the lung apex is longer than the
duration of the CM plateau phase in the pulmonary arteries.
On the other hand, CM volumes in obese patients
calculated from body weight may far exceed the optimum,
which results in an unnecessary iodine load for the kidneys
[12]. If we apply the iodine dose proposed in the literature for
120 kVp pulmonary CTA [10], corresponding to 1.4 mL/kg
CM with 300 mgI/mL concentration, we should have used
CM volumes between 62 and 139 mL in patients weighing
44–99 kg. In contrast, the use of 80 kVp tube energy and a
constant volume of 75mLCMat a concentration of 300mgI/
mL and a flow rate of 3 mL/s provided a mean arterial
attenuation of more than 300 HU in all but six patients with
correct bolus timing. Therefore, low-kVp pulmonary CTA is
Fig. 2 Transverse sections (1-mm-thick) at the level of the right
pulmonary artery from low-dose pulmonary CT angiograms using
80 kVp in four patients with different body weights. a A 44-year-old
female weighing 44 kg. Body surface area (BSA), 1.36 m2; cross-
sectional area of the chest, 485 cm2; soft-tissue thickness of the
chest, 3.7 cm; mean attenuation of the pulmonary arteries, 530
Hounsfield units (HU). b A 71-year-old male weighing 65 kg. BSA,
1.74 m2; cross-sectional area of the chest, 734 cm2; soft-tissue
thickness of the chest, 4.2 cm; mean attenuation of the pulmonary
arteries, 501 HU. c A 44-year-old female weighing 83 kg. BSA,
2.04 m2; cross-sectional area of the chest, 941 cm2; soft-tissue
thickness of the chest, 7.6 cm; mean attenuation of the pulmonary
arteries, 452 HU. d A 56-year-male weighing 95 kg. BSA, 2.23 m2;
cross-sectional area of the chest, 1002 cm2; soft-tissue thickness of
the chest, 6.5 cm; mean attenuation of the pulmonary arteries, 344
HU
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warranted for routine use not only in younger patients to
reduce exposure but also in the elderly with diabetes or
impaired renal function to reduce iodine load [4].
We think that our low-dose pulmonaryCTA protocol has a
potential to be used in pregnant females with suspected PE.
Our routine iodine delivery rate of 0.9 gI/s, which ensured a
mean attenuation of 418 HU in 100 patients and was entirely
sufficient in our collective, can be simply doubled by using
370 mgI/mL CM at a rate of 5 mL/s to counteract the
increased cardiac output and plasma volume in pregnancy
[20–22]. Furthermore, if we accept that subsegmental emboli
do not have an impact on therapeutic decisions, the anatomical
range to be covered can be limited from the level of the aortic
arch to the right hemidiaphragm. Although the justification of
such limited anatomical coverage may be a subject of debate
in older standard patients, it would reduce the estimated
effective dose of our pulmonary CTA protocol by nearly 50%
CNR plotted against body weight
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2
4
6
8
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14
16
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R
r2 = 0.3418;  r = -0.5846; p <0.0001
CNR plotted against body surface area
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Body surface area (m2)
2
4
6
8
10
12
14
16
CN
R
r2 = 0.3344;  r = -0.5783; p <0.0001
CNR plotted against transverse cross sectional area of the chest
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Fig. 3 Scatterplots showing contrast-to-noise ratio as function of a
body weight, b body surface area, c transverse cross-sectional area,
and d soft-tissue thickness of the chest wall. Solid lines are the best-
fit linear regression lines, dotted lines are the 95% regression bands.
CNR Contrast-to-noise ratio, BSA body surface area
Table 4 Correlation of contrast-to-noise ratio (CNR) and subjective
image quality with morphologic parameters of patients (n=100)
CNR Subjective quality
ranking
R P R P
Weight −0.585 <0.001 −0.272 0.006
BMI −0.430 <0.001 −0.235 0.019
BSA −0.582 <0.001 −0.251 0.012
Chest AP diameter −0.457 <0.001 −0.234 0.019
Chest lateral diameter −0.364 <0.001 −0.162 0.116, ns
Chest cross-sectional area −0.544 <0.001 −0.260 0.018
Chest soft-tissue thickness −0.394 <0.001 −0.227 0.023
CNR Contrast-to-noise ratio, BMI body mass index, BSA body
surface area, AP anteroposterior, ns nonsignificant
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to an average of 1mSv and reduce the secondary irradiation to
the fetus, not least by increasing the distance between the
inferior margin of the primary radiation and uterus.
There are some limitations of our study. First, we
concentrated on the objective and subjective qualitative
image criteria for low-dose pulmonary CTA. The evalua-
tion of detection rate of emboli was not our goal and thus
we did not perform a follow-up of the patients or correlate
the images with clinical findings. Second, because of
ethical considerations, 80 kVp was not applied in
individuals with a body weight exceeding 100 kg, since
phantom measurements had predicted a significant dete-
rioration in image quality in these patients. Third, we did
not analyze the utility of the low-dose CT protocol for the
diseases of the lung parenchyma. The thorough investiga-
tion of this issue remains for a further study.
We conclude that pulmonary CTA using 80 kVp and
75 mL of iodinated contrast media provides a good
diagnostic image quality in patients weighing up to 100 kg
and that weight is an appropriate parameter to select those
patients eligible for low-dose pulmonary CTA.
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